(North America, South America, and the Caribbean)
(Including Hong Kong SAR, Macau SAR, and Taiwan)
Leveraging cutting-edge technologies — Miltenyi Biotec® gentleMACS™ Octo, 10x Genomics® Chromium™ X, Illumina®NovaSeq™ X Plus, and Ultima Technology® UG 100™ — Novogene offers end-to-end single cell sequencing solutions from sample processing, library preparation, sequencing, to bioinformatic analysis, delivering high-quality data at competitive prices with a customer-centric approach. This enables researchers to analyze genetic material of individual cells rather than averaging signals across a bulk population of cells. These advancements drive discoveries across diverse fields, such as cancer research and precision oncology, developmental biology, immunology, neuroscience, microbiology and infectious diseases, stem cell research and regenerative medicine, epigenetics and gene regulation, genetic and rare disease research and drug discovery.
Download Now
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.